Recombinant multi-species MAPKAPK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPKAPK2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Ser/Thr protein kinase family. This kinase is regulated through direct phosphorylation by p38 MAP kinase. In conjunction with p38 MAP kinase, this kinase is known to be involved in many cellular processes including stress and inflammatory responses, nuclear export, gene expression regulation and cell proliferation. Heat shock protein HSP27 was shown to be one of the substrates of this kinase in vivo. Two transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: MAP kinase-activated protein kinase 2,MAPK-activated protein kinase 2,MAPKAP kinase 2,MAPKAP-K2,MAPKAPK-2,MAPKAPK2,MK-2,MK2,Mapkapk2,Rps6kc1
Go
to MAPKAPK2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0057-Ag-1/ GM-Tg-hg-IP0057-Ag-2 | Human MAPKAPK2 protein | Human |
| GM-Tg-rg-IP0057-Ag-1/ GM-Tg-rg-IP0057-Ag-2 | Rat MAPKAPK2 protein | Rat |
| GM-Tg-mg-IP0057-Ag-1/ GM-Tg-mg-IP0057-Ag-2 | Mouse MAPKAPK2 protein | Mouse |
| GM-Tg-cynog-IP0057-Ag-1/ GM-Tg-cynog-IP0057-Ag-2 | Cynomolgus/Rhesus macaque MAPKAPK2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0057-Ag-1/ GM-Tg-felg-IP0057-Ag-2 | Feline MAPKAPK2 protein | Feline |
| GM-Tg-cang-IP0057-Ag-1/ GM-Tg-cang-IP0057-Ag-2 | Canine MAPKAPK2 protein | Canine |
| GM-Tg-bovg-IP0057-Ag-1/ GM-Tg-bovg-IP0057-Ag-2 | Bovine MAPKAPK2 protein | Bovine |
| GM-Tg-equg-IP0057-Ag-1/ GM-Tg-equg-IP0057-Ag-2 | Equine MAPKAPK2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0057-Ag-1/ GM-Tg-hg-IP0057-Ag-2;
GM-Tg-rg-IP0057-Ag-1/ GM-Tg-rg-IP0057-Ag-2;
GM-Tg-mg-IP0057-Ag-1/ GM-Tg-mg-IP0057-Ag-2; GM-Tg-cynog-IP0057-Ag-1/ GM-Tg-cynog-IP0057-Ag-2; GM-Tg-felg-IP0057-Ag-1/ GM-Tg-felg-IP0057-Ag-2; GM-Tg-cang-IP0057-Ag-1/ GM-Tg-cang-IP0057-Ag-2; GM-Tg-bovg-IP0057-Ag-1/ GM-Tg-bovg-IP0057-Ag-2; GM-Tg-equg-IP0057-Ag-1/ GM-Tg-equg-IP0057-Ag-2 |
| Products Name | MAPKAPK2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | MAPKAPK2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MAPKAPK2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.